ClinicalTrials.Veeva

Menu

Uterine Artery Ligation to Decrease Blood Loss With Central Placenta Previa

M

Minia Maternity University Hospital

Status

Completed

Conditions

Placenta Previa Without Hemorrhage

Treatments

Procedure: Uterine artery ligation

Study type

Interventional

Funder types

Other

Identifiers

NCT02002026
U1111-1150-4666

Details and patient eligibility

About

This trial will address the effect of uterine artery ligation during Cesarean section in cases with placenta previa to decrease blood loss.

Full description

This Study will address the effect of uterine artery ligation prior to fetal delivery during Cesarean section in cases with central placenta previa to guard against postpartum hemorrhage and to minimize blood loss.

Enrollment

52 patients

Sex

Female

Ages

18 to 49 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Placenta previa is diagnosed when the lowest placental edge is located within 5 cm of the internal os at ultrasound
  • Symptomatic Placenta previa with at least one episode of bleeding
  • Estimated gestational age within 28 to 40 weeks
  • Maternal age > 18 years
  • Informed consent
  • Social affiliation

Exclusion criteria

  • Premature rupture of membranes
  • Severe bleeding.
  • Abnormal fetal heart rates.
  • Pre-eclampsia, chorioamnionitis, severe chronic renal disease.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

52 participants in 2 patient groups, including a placebo group

Ligation group
Active Comparator group
Description:
Uterine artery ligation will be done for patients in this group
Treatment:
Procedure: Uterine artery ligation
Control group
Placebo Comparator group
Description:
Conventional CS
Treatment:
Procedure: Uterine artery ligation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems